Ovarian cancer is newly diagnosed in approximately 25,000 women annually in the United States. It is the fourth leading cause of death from cancer among women and is the most fatal gynecologic malignancy. The overall five-year survival rate is approximately 35%. A fraction (1/5) of ovarian cancers are known to be hereditary and associated with mutations in the BRCA1/2 genes. There is much less known about the genes and pathways that result in sporadic ovarian cancer carcinogenesis. The human ovarian cancer primer library contains primer sets that amplify genes that have been implicated in the carcinogenesis of this disease.